Gianluca Pagnanelli

1.1k total citations
21 papers, 337 citations indexed

About

Gianluca Pagnanelli is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Gianluca Pagnanelli has authored 21 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Dermatology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Gianluca Pagnanelli's work include Psoriasis: Treatment and Pathogenesis (14 papers), Dermatology and Skin Diseases (8 papers) and Autoimmune Bullous Skin Diseases (4 papers). Gianluca Pagnanelli is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (14 papers), Dermatology and Skin Diseases (8 papers) and Autoimmune Bullous Skin Diseases (4 papers). Gianluca Pagnanelli collaborates with scholars based in Italy, United States and Netherlands. Gianluca Pagnanelli's co-authors include Martina Morelli, Claudia Scarponi, Andrea Cavani, Cristina Albanesi, Stefania Madonna, Laura Mercurio, Cristina Maria Failla, Maria Luigia Carbone, Charles A. Dinarello and Emanuela Gubinelli and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Cell Death and Disease.

In The Last Decade

Gianluca Pagnanelli

18 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianluca Pagnanelli Italy 9 236 165 101 55 46 21 337
Monika Zabłotna Poland 12 228 1.0× 159 1.0× 65 0.6× 63 1.1× 43 0.9× 45 374
So Yeon Paek United States 10 188 0.8× 186 1.1× 48 0.5× 42 0.8× 46 1.0× 27 385
Helena Iznardo Spain 10 163 0.7× 131 0.8× 64 0.6× 58 1.1× 31 0.7× 17 297
Leire González‐Lara Spain 13 328 1.4× 152 0.9× 72 0.7× 84 1.5× 50 1.1× 22 433
Line Raaby Denmark 9 234 1.0× 117 0.7× 51 0.5× 52 0.9× 71 1.5× 15 344
Kati Asumalahti Finland 7 390 1.7× 173 1.0× 79 0.8× 110 2.0× 73 1.6× 10 496
Markus Friedrich Germany 8 238 1.0× 147 0.9× 48 0.5× 45 0.8× 37 0.8× 14 331
Petra Cetkovská Czechia 10 132 0.6× 174 1.1× 29 0.3× 41 0.7× 30 0.7× 32 345
Julia Wagenpfeil Germany 5 192 0.8× 143 0.9× 53 0.5× 64 1.2× 55 1.2× 15 298
Karl M. Hoegler United States 6 115 0.5× 103 0.6× 36 0.4× 24 0.4× 32 0.7× 15 244

Countries citing papers authored by Gianluca Pagnanelli

Since Specialization
Citations

This map shows the geographic impact of Gianluca Pagnanelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Pagnanelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Pagnanelli more than expected).

Fields of papers citing papers by Gianluca Pagnanelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Pagnanelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Pagnanelli. The network helps show where Gianluca Pagnanelli may publish in the future.

Co-authorship network of co-authors of Gianluca Pagnanelli

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Pagnanelli. A scholar is included among the top collaborators of Gianluca Pagnanelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Pagnanelli. Gianluca Pagnanelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moretta, Gaia, Gianluca Pagnanelli, Diego Orsini, et al.. (2025). Psoriasis and Emotional Dysregulation: A Multicenter Analysis of Psychodermatology Outcomes. Dermatology Practical & Conceptual. 15(2). 4644–4644. 1 indexed citations
3.
Bernardini, Nicoletta, Annunziata Dattola, Gianluca Pagnanelli, et al.. (2024). Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study. Journal of Personalized Medicine. 14(12). 1169–1169. 1 indexed citations
4.
Dattola, Annunziata, Nicoletta Bernardini, Giacomo Caldarola, et al.. (2024). Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region. Dermatology Practical & Conceptual. 14(3). e2024166–e2024166. 3 indexed citations
5.
Zangrilli, Arianna, Giacomo Caldarola, Viviana Lora, et al.. (2024). Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study. International Journal of Dermatology. 63(10). 1383–1391. 1 indexed citations
6.
Caldarola, Giacomo, Mauro Bavetta, Nicoletta Bernardini, et al.. (2023). 2‐Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy. Dermatologic Therapy. 2023(1). 2 indexed citations
7.
Caldarola, Giacomo, Arianna Zangrilli, Mauro Bavetta, et al.. (2023). Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience. Drugs in Context. 12. 1–5. 5 indexed citations
8.
Moro, Francesco, Feliciana Mariotti, Naomi De Luca, et al.. (2022). Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis. Frontiers in Medicine. 9. 1055045–1055045.
9.
Caldarola, Giacomo, Arianna Zangrilli, Nicoletta Bernardini, et al.. (2022). Risankizumab for the treatment of moderate‐to‐severe psoriasis: A multicenter, retrospective, 1 year real‐life study. Dermatologic Therapy. 35(6). e15489–e15489. 17 indexed citations
10.
Caldarola, Giacomo, Marco Galluzzo, Nicoletta Bernardini, et al.. (2022). Tildrakizumab in moderate‐to‐severe plaque psoriasis: A multicenter, retrospective, real‐life study. Dermatologic Therapy. 35(6). e15488–e15488. 21 indexed citations
11.
Zangrilli, Arianna, Giacomo Caldarola, Nicoletta Bernardini, et al.. (2021). Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert Opinion on Biological Therapy. 21(9). 1291–1298. 7 indexed citations
12.
Fortes, Cristina, Simona Mastroeni, Maria Capuano, et al.. (2021). Differences in individual and environmental factors between cutaneous melanoma and atypical Spitz tumour in children and adolescents. European Journal of Pediatrics. 181(1). 263–269. 3 indexed citations
13.
Carbone, Maria Luigia, Pedro Miguel Lacal, Laura De Giglio, et al.. (2020). Multiple Sclerosis Treatment and Melanoma Development. International Journal of Molecular Sciences. 21(8). 2950–2950. 15 indexed citations
14.
Mercurio, Laura, Cristina Maria Failla, Claudia Scarponi, et al.. (2020). Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. PLoS ONE. 15(4). e0222969–e0222969. 47 indexed citations
15.
Failla, Cristina Maria, Maria Luigia Carbone, Cristina Fortes, Gianluca Pagnanelli, & Stefania D’Atri. (2019). Melanoma and Vitiligo: In Good Company. International Journal of Molecular Sciences. 20(22). 5731–5731. 41 indexed citations
16.
Fania, Luca, Martina Morelli, Claudia Scarponi, et al.. (2019). Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development. The Journal of Pathology Clinical Research. 6(1). 55–68. 26 indexed citations
17.
Mercurio, Laura, Martina Morelli, Claudia Scarponi, et al.. (2018). IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death and Disease. 9(11). 1104–1104. 111 indexed citations
18.
Pagnanelli, Gianluca, R. Bono, Maria Antonietta Pizzichetta, et al.. (2007). Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity.. PubMed. 27(4C). 2939–44. 8 indexed citations
19.
Piccolo, Domenico, H. Peter Soyer, Sergio Chimenti, et al.. (2004). Diagnosis and categorization of acral melanocytic lesions using teledermoscopy. Journal of Telemedicine and Telecare. 10(6). 346–350. 27 indexed citations
20.
Piccolo, Domenico, H. Peter Soyer, Maria Sole Chimenti, et al.. (2002). Reproducibility of Saida's classification for acral pigmented skin lesions through a teledermoscopic study. Experimental Dermatology. 11(3). 282–282. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026